Free Trial

Denali Therapeutics (DNLI) Earnings Date, Estimates & Call Transcripts

$19.98
-0.15 (-0.75%)
(As of 05/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 7)
-$0.68 Beat By $0.01
Consensus EPS
(May. 7)
-$0.69
Skip Charts & View Estimated and Actual Earnings Data

DNLI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DNLI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Denali Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20244($0.81)($0.61)($0.71)
Q2 20245($0.78)($0.62)($0.69)
Q3 20245($0.76)($0.49)($0.65)
Q4 20245($0.80)($0.53)($0.68)
FY 202419($3.15)($2.25)($2.73)
Q1 20251($0.67)($0.67)($0.67)
Q2 20251($0.65)($0.65)($0.65)
Q3 20251($0.68)($0.68)($0.68)
Q4 20251($0.75)($0.75)($0.75)
FY 20254($2.75)($2.75)($2.75)

DNLI Earnings Date and Information

Denali Therapeutics last issued its quarterly earnings results on May 7th, 2024. The reported ($0.68) EPS for the quarter, beating analysts' consensus estimates of ($0.69) by $0.01. Denali Therapeutics has generated ($0.96) earnings per share over the last year (($0.96) diluted earnings per share). Earnings for Denali Therapeutics are expected to decrease in the coming year, from ($2.77) to ($2.82) per share. Denali Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Denali Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/7/2024Q1 2024($0.69)($0.68)+$0.01($0.68)$14.02 million-
2/27/2024Q4 2023($0.81)($0.86)($0.05)($0.86)$3.38 million-
11/7/2023Q3 2023($0.81)($0.72)+$0.09($0.72)$11.16 million$1.30 million    
8/8/2023Q2 2023($0.69)$1.30+$1.99$1.30$39.51 million$294.10 million
5/8/2023Q1 2023($0.70)($0.80)($0.10)($0.80)$29.88 million$35.14 million
2/27/2023Q4 2022($0.77)($0.75)+$0.02($0.75)$11.29 million$10.28 million
11/3/2022Q3 2022($0.83)($0.84)($0.01)($0.84)$10.06 million$3.56 million
8/8/2022Q2 2022($0.52)($0.48)+$0.04($0.48)$44.66 million$52.50 million
5/5/2022Q1 2022($0.47)($0.53)($0.06)($0.53)$33.32 million$42.10 million
2/28/2022Q4 2021($0.41)($0.62)($0.21)($0.62)$38.16 million$12.51 million    
11/4/2021Q3 2021($0.46)($0.69)($0.23)($0.69)$30.28 million$5.29 million
8/4/2021Q2 2021($0.36)($0.50)($0.14)($0.50)$27.92 million$22.94 million
5/2/2021Q1 2021($0.34)($0.58)($0.24)($0.58)$31.62 million$7.90 million  
2/25/2021Q4 2020($0.09)$1.91+$2.00$1.91$87.98 million$316.82 million  
11/5/2020Q3 2020$4.19($0.54)($4.73)($0.54)$564.69 million$9.39 million  
8/7/2020Q2 2020($0.61)($0.56)+$0.05($0.56)$3.71 million$5.85 million  
5/7/2020Q1 2020($0.57)($0.55)+$0.02($0.55)$5.93 million$3.60 million
2/27/2020Q4 2019($0.58)($0.56)+$0.02($0.56)$15.71 million$4.67 million
11/6/2019Q3($0.5630)($0.48)+$0.0830($0.48)$10.86 million$13.60 million  
8/6/2019Q2 2019($0.46)($0.61)($0.15)($0.61)$4.52 million$4.20 million  

Denali Therapeutics Earnings - Frequently Asked Questions

When is Denali Therapeutics's earnings date?

Denali Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on DNLI's earnings history.

Did Denali Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Denali Therapeutics (NASDAQ:DNLI) reported ($0.68) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.69) by $0.01. Learn more on analysts' earnings estimate vs. DNLI's actual earnings.

How much revenue does Denali Therapeutics generate each year?

Denali Therapeutics (NASDAQ:DNLI) has a recorded annual revenue of $330.53 million.

How much profit does Denali Therapeutics generate each year?

Denali Therapeutics (NASDAQ:DNLI) has a recorded net income of -$145.22 million. DNLI has generated -$0.96 earnings per share over the last four quarters.

What is Denali Therapeutics's EPS forecast for next year?

Denali Therapeutics's earnings are expected to decrease from ($2.77) per share to ($2.82) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:DNLI) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners